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Abstract
The External Quality Assessment (EQA) in Brazil is performed by the National Health Ministry for diseases that are under supervision of Public Health 
Department. In addition to the government program, the Brazilian Society of Clinical Analysis and the Brazilian Society of Medical Pathology are 
allowed to provide their programs under the Supervision of National Agency for Sanitary Surveillance (ANVISA) that regulates laboratories to per-
form EQA programs.
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Introduction
External Quality Assessment (EQA) and Proficiency 
Testing (PT) are valuable tools in the quality im-
provement process. EQA in clinical laboratory 
could be described as a set of systematic, data-
guided activities, designed to bring improvements 
in health care delivery, and the combined efforts 
of everyone to make changes that will potentially 
lead to better patient outcomes, better system 
performance, and better professional develop-
ment (1,2).
To be successful, PT instructions must be followed 
carefully, all paper work completed accurately, and 
results submission deadlines met. All PT results, as 
well as corrective actions, should be recorded and 
the records maintained for an appropriate period 
of time. PT is a tool to measure laboratory perfor-
mance. Therefore, there must be no difference in 
the treatment of PT samples and the patient’s 
sample. Proficiency testing providers make every 
effort to produce samples that exactly mimic, or 
closely resemble, usual samples received from pa-
tients. PT samples must be processed by normal 
testing method(s) and involve personnel who rou-
tinely perform the testing.
The internal quality control (QC) involves in-house 
procedures for continuously and concurrently as-
sessing laboratory work so that results produced 
by the laboratory can then be decided whether 
they are reliable enough to be released for sup-
porting quality patient care. The mean and stand-
ard deviation (SD) values must be calculated or 
evaluated before a new lot of QC material is used. 
The SD value should be derived from the labora-
tory established precision goals for each analyte 
(3). Acceptable ranges (confidence limits) must be 
defined for internal quality control material. Where 
acceptable ranges are set to limits other than ± 
2SD based on current analytical performance, the 
rationale for the limits should be documented.
Several efforts have been done for making EQA/
PT schemes web friendly in recent years. Both data 
entry and result review are available via internet in 
many programs. This strongly reduces time in 
sending and receiving EQA/PT reports. It also re-
duces the risk of manual transcription of data and 
results.
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EQA in Brazil
The EQA in Brazil is performed by the National 
Health Ministry for diseases that are under super-
vision of Public Health Department. Brazilian clini-
cal laboratories must follow a specific sanitary leg-
islation since 2005. The RDC 302/2005 is a broad 
technical regulation aiming to guarantee the qual-
ity of the examinations carried out by approxi-
mately 17.000 laboratories existing in the country 
(4). In this way, the internal quality control, with 
the new legislation, has become a mandatory task 
within the laboratories, aiming to assure the quali-
ty of the laboratory results.
In addition to the government program, the Brazil-
ian Society of Clinical Analysis (SBAC) and the Bra-
zilian Society of Medical Pathology (SBPC) are al-
lowed to provide their programs under the Super-
vision of National Agency for Sanitary Surveillance 
(ANVISA) that regulates laboratories to perform 
EQA programs.
The National Program of Quality Control (PNCQ), 
supported by SBAC, is a producer of quality con-
trol samples for EQA that had started to organize 
and to coordinate programs for the External Qual-
ity Assessment Laboratory forty years ago. Cur-
rently 63 schemes covering 352 different tests are 
available.
PNCQ sends periodically (monthly or quarterly) 
multiple samples to the laboratories for analysis 
and/or identification in the first or second week of 
the month. The participating laboratory receives 
the samples, analyses them and sends the results 
until the 5th day of the following month. Each lab-
oratory’s results are compared with those of other 
laboratories in the group and/or with an assigned 
value, and reported to the participating laborato-
ries and others. Upon receipt, the results are 
grouped by method or equipment, and analysed 
to calculate the mean, SD and coefficient of varia-
tion using its own software (5). The Program re-
leases the results, which are available to members 
on the PNCQ site in 48 hours.
The PNCQ’s participating laboratory can establish 
the mean and SD values, as well as elaborate the 
internal control charts, using the “PRO-IN Real 
Time” program, available at its website. The use of 
this tool eliminates the need for manual prepara-
tion of the Levey-Jennings Chart and the partici-
pant laboratory can view and compare their aver-
ages with that of all other participants.
Following the regulation of RDC 302 in 2005, qual-
ity control programs in Brazil experienced a signifi-
cant increase in the number of participants (Figure 
1). According to information from CNES – DATA-
SUS, there are about 16,700 clinical analysis labora-
tories and 5,800 pathology/cytology laboratories 
in the country located mainly in the southeast 
(38.9%) and northeast (27.3%) regions (6). These 
numbers include laboratories that are in hospitals, 
clinics and other health facilities with or without 
hospitalization.
By now, the Program has 5.028 participants distrib-
uted as 4871 clinical laboratories, 50 cytopatholo-
gy laboratories, 17 centres of molecular biology di-
agnostic and 90 blood banks. The Program reach-
es all the 26 states of the country, 7 countries of 
South America, besides Costa Rica, Italy, Spain, 
Portugal and Finland. Among the participants, 
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State Universities and 175 Laboratories outside the 
country.
Because of the size of the country and the distance 
of some of the partner countries in Latin America 
and Europe, we started, in 2009, the production of 
lyophilized samples to ensure the sample quality 
and stability even without fast and adequate de-
livery. In 2010, PNCQ started production of freeze-
dried samples of bacteria and distribute them to 
participants of the Program. In 2015, the Program 
produced 861,573 samples; 619,674 lyophilized. At 
the moment the Program analyses 3,5 million re-
sults by year. All the samples are continuing tested 
for homogeneity and stability in order to provide 
the quality of the produced samples.
Conclusions
The EQA and PT are valuable tools in the quality 
improvement process of clinical laboratory services 
(7,8). However, the primary objectives of EQA are 
educational, and may be supported by specific 
schemes aimed to extend the evaluation through-
out all phases of the testing cycle, including inter-
pretation of results.
In pursuit of that goal, the SBAC works together 
with the PNQC looking for the awareness of labora-
tory professionals for their continued professional 
development. The existence of the two organiza-
tions, walking together for 40 years brings a mix of 
its activities and purposes. The constant partner-
ship can be evidenced in the numerous events that 
SBAC and PNCQ complete themselves in its main 
objectives.
The main mission of the Program is to help labora-
tories to implement the external and internal qual-
ity control in order to ensure the quality of test re-
sults and obey the country’s laws. There is a part-
nership between SBAC and PNCQ offering dis-
counts on quality programs to SBAC members. 
The PNCQ also organizes during the SBAC Confer-
ence a set of workshops addressing the key ques-
tions of the participants sent to scientific advice 
during the year.
In all editions, the SBAC Conference also offers the 
training course for quality auditors and the course 
of PNCQ manager. These courses provide an op-
portunity to members to implement the quality 
system in their laboratories or improve the man-
agement of quality processes achieving qualifica-
tion to perform audits.
Accreditation of the Quality Management System 
(DICQ) is a significant differentiation for the clinical 
analyses laboratories (9). Not only with relation to 
the control of all the procedures or the productivi-
ty increase with the use of standardized docu-
ments, but also to demonstrate their competence 
through formal compliance with a set of interna-
tionally-recognized requirements for the planning 
and implementation of proficiency testing pro-
grams. There are currently 300 laboratories ac-
credited by DICQ in Brazil. Accreditation provides 
to the users an increased confidence that the 
schemes are being operated competently in ac-
cordance with specified technical and manage-
ment system requirements. 
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